114 related articles for article (PubMed ID: 10740203)
1. A tobacco-specific carcinogen in the fetus.
Milunsky A; Carmella SG; Ye M; Hecht SS
Prenat Diagn; 2000 Apr; 20(4):307-10. PubMed ID: 10740203
[TBL] [Abstract][Full Text] [Related]
2. Metabolites of a tobacco-specific carcinogen in urine from newborns.
Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
[TBL] [Abstract][Full Text] [Related]
3. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
[TBL] [Abstract][Full Text] [Related]
4. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
6. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
7. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
10. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
Carmella SG; Ye M; Upadhyaya P; Hecht SS
Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
[TBL] [Abstract][Full Text] [Related]
11. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
[TBL] [Abstract][Full Text] [Related]
12. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
13. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.
Hecht SS; Ye M; Carmella SG; Fredrickson A; Adgate JL; Greaves IA; Church TR; Ryan AD; Mongin SJ; Sexton K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1109-16. PubMed ID: 11700257
[TBL] [Abstract][Full Text] [Related]
15. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
Hecht SS; Chung FL; Richie JP; Akerkar SA; Borukhova A; Skowronski L; Carmella SG
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661
[TBL] [Abstract][Full Text] [Related]
16. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke.
Parsons WD; Carmella SG; Akerkar S; Bonilla LE; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):257-60. PubMed ID: 9521443
[TBL] [Abstract][Full Text] [Related]
17. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
18. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
[TBL] [Abstract][Full Text] [Related]
19. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
[TBL] [Abstract][Full Text] [Related]
20. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
